Schistosomiasis is one of the most prevalent parasitic diseases, infecting over 206 millions of people all over the world \[[@b1-kjp-53-1-129]\]. It was estimated that 112 million people were infected with *S. haematobium* \[[@b2-kjp-53-1-129]\]. Despite enormous number of people infected with *S. haematobium*, empirical studies on genetic diversity of natural *S. haematobium* are minimal \[[@b3-kjp-53-1-129],[@b4-kjp-53-1-129]\]. For instance, by using enzyme analyses, 22 laboratory bred isolates of *S. haematobium* have shown regional genetic variation \[[@b5-kjp-53-1-129]\]. Moreover, sequence variation has been demonstrated in the complete mitochondrial genome of *S. haematobium*, showing population level differences \[[@b6-kjp-53-1-129]\]. More recently, microsatellite markers, which is a powerful tool for genotyping in use today \[[@b7-kjp-53-1-129]\], have been developed for *S. haematobium* \[[@b8-kjp-53-1-129]\]. However, little is known about the genetic diversity of natural *S. haematobium* populations from the human host.

The inaccessibility of adult *S. haematobium* worms, due to their sequestration within the vasculature of the human host, is the main limitation to investigate the genetic diversity of natural *S. haematobium*. The laboratory harvest of adult worms involves collection of eggs from the urine of infected individuals and subsequent passage through laboratory populations of snails and rodents \[[@b9-kjp-53-1-129]\]. This laborious approach inevitably introduces a bias, as those parasitic genotypes that were better adapted for laboratory hosts may be artificially selected, and thus could be poor representatives of natural populations \[[@b10-kjp-53-1-129]\].

Pooling of templates has been suggested to reduce the cost of genotyping individuals \[[@b11-kjp-53-1-129]\], especially when inadequate DNA is available from single samples. Pooled DNA samples have been applied to assess allele frequencies in various DNA samples \[[@b12-kjp-53-1-129]\]. In a novel study, pooling DNA was tested for *S. mansoni* miracidia by using laboratory isolates and synthetic pools \[[@b13-kjp-53-1-129]\]. It was suggested that pooling is a reliable way to reconstruct genetic features of the population, from which microsatellite allele frequencies can be estimated \[[@b13-kjp-53-1-129]\]. In this study, by using 4 published microsatellite loci, we genotyped individually pooled *S. haematobium* eggs of patients\' urine samples from 4 locations in the endemic areas of Mali and Nigeria. We aimed to explore the differences in allelic diversity and composition among the populations.

By applying a set of microsatellite markers, we genotyped pooled eggs of *S. haematobium* sampled directly from patients'urine samples. The *S. haematobium* egg samples were collected from 3 locations in Nigeria (Ebonyi, Bayelsa, and Ogun) and 1 location in Mali (Bamako) ([Fig. 1](#f1-kjp-53-1-129){ref-type="fig"}). The egg samples were obtained by filtering single urine samples of infected primary school students, during May to November 2011. In total, 22 patients from Nigeria and 27 patients from Mali were enrolled for this study; all the patients were confirmed by the presence of *S. haematobium* eggs in the urine. The urine samples were then concentrated, and 5 eggs from each patient sample were fixed on Whatman FTA cards. The egg samples were delivered to the National Institute of Parasitic Diseases (NIPD), Chinese Center for Disease Control and Prevention (China CDC) for the study. The study protocol was approved by the Institutional Ethics Committee of NIPD, China CDC. The investigation aim, potential risks, and the benefits were explained to the participants, and the informed consents were obtained verbally. Treatment was followed to the subjects enrolled.

The DNA was extracted from each egg pool by using the DNeasy Blood & Tissue Kit (QIAGEN, Hilden, Germany), according to the method described by Reinstrup et al. \[[@b14-kjp-53-1-129]\], and stored at 4°C for use. We genotyped each DNA sample using 4 microsatellite markers (A1, A6, B4, and C2) \[[@b8-kjp-53-1-129]\]. All PCRs were performed on a GeneAmp PCR System 9700 thermal cycler (Applied Biosystems, Foster City, California, USA). According to the protocol reported \[[@b8-kjp-53-1-129]\], the PCR products were diluted in autoclaved de-ionized water, and then analyzed on an ABI 3730 capillary automated sequencer, by using a LIZ 500 labelled size standard. Allele sizes were read using GeneMapper version 4.0 (Applied Biosystems). Across different runs of genotyping, the consistency of alleles was examined with 1 *Schistosoma* genotype as a reference in each run. Alleles at each locus were determined based on the base-pair length of the fragments, and compared with the reference genotype.

For each locus, we applied Student's t-test to compare the mean allele number of individuals between Mali and Nigeria, with R-software \[[@b15-kjp-53-1-129]\]. In addition, we compared the allelic composition among the populations at location level (Ebonyi, Bayelsa, and Ogun) within Nigeria for each locus, using a r×c test \[[@b16-kjp-53-1-129]\]. As 4 loci were tested, sequential Bonferroni corrections were applied when interpreting the results. Finally, we used a Monte Carlo approach with 10^5^ simulation runs \[[@b17-kjp-53-1-129]\], to compare the allelic composition between the Mali and Nigeria samples.

The results indicated that the mean allele number ranged from 2.3 to 5.9 across all loci, and the allele size ranged 110-232 bp at locus A1, 103-364 at A6, 118-365 at B4, and 107-360 at C2 ([Table 1](#t1-kjp-53-1-129){ref-type="table"}). Secondly, we found that the mean number of alleles per locus in the population from Mali was significantly higher than that from Nigeria at the locus A6 (5.8 vs 4.3 alleles; *t*=2.32, *P*=0.02), B4 (5.9 vs 2.3; *t*=4.76, *P*\<0.001), and C2 (4.3 vs 2.3; *t*=4.38, *P*\<0.001), except at A1 (5.1 vs 4.7; *t*=0.86; *P*=0.39) ([Table 2](#t2-kjp-53-1-129){ref-type="table"}). We did not detect significant differences in allelic composition among the samples from 3 locations in Nigeria at any of the 4 loci, assessed by the Monte Carlo simulation approach ([Fig. 2](#f2-kjp-53-1-129){ref-type="fig"}). Meantime, the results showed that the allelic composition differed significantly between the Mali and Nigeria populations at 3 loci (A6, B4, and C2), but not at A1 (*P*=0.25) ([Fig. 3](#f3-kjp-53-1-129){ref-type="fig"}).

The levels of genetic diversity was an important indicator for monitoring the effects of selective pressure imposed by drug treatment and may be a key epidemiologocal component \[[@b18-kjp-53-1-129]\]. The genetic diversity was reported to be unexpectedly low in *S. haematobium*, by using DNA barcoding approaches \[[@b19-kjp-53-1-129]\]. However, we found that high allelic diversity of *S. haematobium* exists in the populations in Mali and Nigeria, which is consistent with the results previously reported \[[@b20-kjp-53-1-129]\]. It is because the microsatellite marker is particularly powerful to detect nucleotide polymorphisms in *S. haematobium* populations \[[@b4-kjp-53-1-129]\]. We also found that the allelic richness of individuals in Mali was higher than that in Nigeria. Referring to the fact that the estimated prevalence of schistosomiasis was 60% in Mali and 23.2% in Nigeria in 2003 \[[@b21-kjp-53-1-129]\], our result supports the view that the higher prevalence of parasite may be closely related to the genetic diversity of parasite populations \[[@b22-kjp-53-1-129]\]. The lower prevalence of schistosomiasis in Nigeria may lead to less gene flow and thus reduce the genetic diversity. It was not surprising that this pattern was consistent with the most recent findings that the *S. haematobium* population from Zanzibar having a high prevalence of schistosomiasis possesses larger number of alleles, whereas the lower number of alleles occurred in the South Africa with a low prevalence \[[@b21-kjp-53-1-129],[@b23-kjp-53-1-129]\]. However, the genetic diversity in terms of average allele number in this study did not show significant difference between Ebonyi and Bayelsa samples from Nigeria (excluding the Ogun sample which was collected from only 1 patient; data not shown). The explanation would be that Ebonyi and Bayelsa are closely located, thus a potential gene flow would be expected between.

Previous studies have suggested that human movements within a country may lead to significant gene flow between *S. mansoni* populations \[[@b20-kjp-53-1-129]\]. Since both Ebonyi and Ogun are in forest zones, more human movements and water contacts would occur, comparing with Mali, which is largely in the Sahara desert. Therefore, the higher gene flow among the *Schistosoma* populations in Nigeria might reduce the opportunities of local adaptations, leading to a lower population differentiation among the populations. When comparing the allelic composition between Mali and Nigeria, significant difference was found, suggesting high population differentiation may occur in the 2 endemic countries.

Applying microsatellite markers and different developmental stages for genotyping *S. haematobium*, significant genetic diversity was determined in the populations in Africa where the disease prevalence varies among countries. By using *S. haematobium* individual miracidium hatched with the eggs from patients in Mali, it was found that there was only limited evidence of population subdivision between individuals or sampling locations \[[@b4-kjp-53-1-129]\]. Based on the microsatellite analysis on individual miracidium from patient's egg samples, high levels of genetic diversity were detected in S. mansoni and *S. haematobium* populations at the country level, but not at regional level, across 6 sub-Saharan African countries \[[@b20-kjp-53-1-129]\]. Most recently, Glenn et al. \[[@b23-kjp-53-1-129]\] developed highly variable DNA markers for individual adult worms of *S. haematobium* from laboratory animals, and detected significant variance in genetic diversity and differentiation among populations of *S. haematobium* in Africa. Our study demonstrated significant difference of genetic variation of *S. haematobium* between the populations from Mali and Nigeria, but no evidence of population variance within Nigeria. The results support the previous findings that genetic variation exists in the *S. haematobium* populations in Africa at country level, and it may be related to the varied prevalence of the disease in different countries.

We used pooled DNA of eggs from each patient, for the first time, to genotype natural *S. haematobium*. An approach using pooled DNA of individual cloned adult worms of a laboratory strain was proposed for studying population genetics of *S. mansoni*, presenting a good correlation between the pooled values and the true allele frequencies \[[@b13-kjp-53-1-129]\]. Although this method can be used for larger scale of genotyping, it should be recognized that it has potential limitations. The pooled data could not be assessed by using Hardy-Weinberg probability and other parameters for population differentiation, and the estimation accuracy of genotype frequency is depending on how the pool is made. If a pool contains all parasites from each individual, sampling bias could be minimized. The number of eggs for DNA pool, samples, and the microsatellite loci was limited in our study, thus limit the power to estimate the population genetic diversity, and to reduce sampling bias. As commonly acknowledged, a best way to evaluate intra- and inter-population genetic structures and variations at the individual host level is to use DNA derived from single genotypes. Although there are shortcomings, the parasite egg stage, we used, could be a simpler and lower labour-consuming way to study genetic variation of *Schistosoma* from the definitive host. However, when using pooled egg DNA to assess the allele frequency of parasites, the DNA pool should be prepared using all eggs or a larger number of eggs from each individual to reduce sampling bias. To evaluate population differentiation, individual eggs and more microsatellite loci should be applied for further study.
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###### 

Allele counts of *S. haemabobium* from 4 locations in Africa

  Locus                  Mali   Nigeria           Locus      Mali   Nigeria                                    
  ------- -------------- ------ --------- --- --- ------- -- ------ --------- -------------- ---- ---- --- --- ----
          No. patients   20     16        5   1   22                          No. patients   27   14   5   1   20
  A1      110            2      0         0   0   0                 B4        118            6    1    0   0   1
          113            2      2         0   0   2                           124            0    2    0   0   2
          116            1      2         0   0   2                           129            2    2    0   0   2
          119            0      3         0   0   3                           138            1    3    0   1   4
          123            0      2         0   0   2                           146            3    0    0   0   0
          133            0      1         0   0   1                           149            0    1    0   0   1
          196            0      1         0   0   1                           166            1    1    0   0   1
          199            0      1         0   0   1                           192            3    2    4   0   6
          204            0      1         0   0   1                           209            22   2    1   0   3
          217            18     10        5   1   16                          212            22   4    0   1   5
          221            19     13        5   1   19                          215            24   4    2   1   7
          224            20     13        5   1   19                          221            0    1    0   0   1
          228            20     14        5   1   20                          249            1    0    0   0   0
          232            19     10        5   1   16                          256            0    4    0   0   4
          No. patients   27     16        4   1   21                          266            0    1    0   0   1
  A6      103            21     9         4   1   14                          274            18   2    0   0   2
          106            9      1         1   0   2                           277            18   2    0   0   2
          109            6      1         1   0   2                           280            18   2    0   0   2
          115            14     3         2   1   6                           340            8    0    0   0   0
          119            11     2         0   0   2                           346            8    0    0   0   0
          123            12     4         4   0   8                           365            0    1    0   0   1
          129            15     9         4   0   13                          No. patients   27   16   5   1   22
          132            1      2         0   0   2                 C2        107            2    0    0   0   0
          135            1      0         0   0   0                           111            1    0    0   0   0
          145            1      0         0   0   0                           117            7    0    0   0   0
          148            3      2         0   0   2                           123            18   9    4   0   13
          151            3      1         0   0   1                           132            18   0    0   0   0
          158            3      0         0   0   0                           147            0    2    0   0   2
          163            1      1         0   0   1                           157            3    0    0   0   0
          168            0      3         0   0   3                           171            1    1    0   0   1
          181            8      10        1   1   12                          178            1    0    0   0   0
          192            6      1         0   0   1                           190            14   11   4   1   16
          197            0      2         0   0   2                           199            16   0    0   0   0
          201            1      0         0   0   0                           210            4    0    0   0   0
          220            19     11        4   1   16                          219            2    1    0   0   1
          223            2      0         0   0   0                           238            9    1    1   0   2
          226            4      0         0   0   0                           267            5    0    0   0   0
          229            1      0         0   0   0                           281            0    1    0   0   1
          238            5      0         0   0   0                           291            2    1    0   0   1
          252            1      0         0   0   0                           298            1    1    0   0   1
          287            4      0         0   0   0                           316            5    0    0   0   0
          321            0      1         0   0   1                           321            0    1    0   0   1
          328            0      1         0   0   1                           330            0    3    0   0   3
          334            1      0         0   0   0                           336            4    3    1   0   4
          340            1      0         0   0   0                           350            0    1    0   0   1
          364            0      3         0   0   3                           360            2    3    0   0   3
                                                                              390            0    1    0   0   1

###### 

Characteristics of microsatellite assay for *S. haematobium* from 4 locations in Africa

  Allele character         A1        A6        B4        C2                                      
  ------------------------ --------- --------- --------- --------- --------- --------- --------- ---------
  No. patients tested      20        22        27        21        27        20        27        22
  Average no. alleles      5.1       4.7       5.8       4.3       5.9       2.3       4.3       2.3
  Range of allele number   2-7       1-8       2-10      1 -8      1-10      1 -8      1-9       1 -5
  Range of allele size     110-232   113-232   103-340   103-364   118-346   118-365   107-360   123-360
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